Advanced company searchLink opens in new window

NANOFORM CARDIOVASCULAR THERAPEUTICS LIMITED

Company number 07203553

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
25 Sep 2014 AA Total exemption full accounts made up to 31 December 2013
27 May 2014 AR01 Annual return made up to 25 March 2014 with full list of shareholders
Statement of capital on 2014-05-27
  • GBP 10,000
03 Oct 2013 AA Total exemption full accounts made up to 31 December 2012
01 May 2013 TM02 Termination of appointment of Beach Secretaries Limited as a secretary
01 May 2013 AR01 Annual return made up to 25 March 2013 with full list of shareholders
12 Apr 2013 AP01 Appointment of Gabor Heltovics as a director
12 Apr 2013 TM01 Termination of appointment of David Tapolczay as a director
12 Apr 2013 TM01 Termination of appointment of Gergely Darvas as a director
11 Mar 2013 CH01 Director's details changed for Mr Gergely Darvas on 22 February 2013
21 Feb 2013 AD01 Registered office address changed from 100 Fetter Lane London EC4A 1BN United Kingdom on 21 February 2013
29 Nov 2012 MG01 Particulars of a mortgage or charge / charge no: 1
04 Oct 2012 AA Total exemption small company accounts made up to 31 December 2011
20 Apr 2012 AR01 Annual return made up to 25 March 2012 with full list of shareholders
10 Jan 2012 TM01 Termination of appointment of Alan Chorlton as a director
21 Dec 2011 SH01 Statement of capital following an allotment of shares on 8 December 2011
  • GBP 10,000
04 Oct 2011 AA Total exemption full accounts made up to 31 December 2010
26 Apr 2011 AR01 Annual return made up to 25 March 2011 with full list of shareholders
31 Jan 2011 SH14 Redenomination of shares. Statement of capital 30 December 2010
31 Jan 2011 RESOLUTIONS Resolutions
  • RES 17 ‐ Resolution to redenominate shares
09 Sep 2010 AP01 Appointment of Dr Alan Paul Chorlton as a director
09 Sep 2010 AP01 Appointment of Dr David Tapolczay as a director
09 Sep 2010 SH01 Statement of capital following an allotment of shares on 17 August 2010
  • EUR 1
  • GBP 5,999.00
01 Jul 2010 AA01 Current accounting period shortened from 31 March 2011 to 31 December 2010
17 Apr 2010 CERTNM Company name changed nanoform therapeutics LIMITED\certificate issued on 17/04/10
  • RES15 ‐ Change company name resolution on 2010-04-07
17 Apr 2010 CONNOT Change of name notice